Last updated: June 27, 2024
Sponsor: Loyola University
Overall Status: Terminated
Phase
4
Condition
Ileus
Treatment
Naloxone
Clinical Study ID
NCT03176316
209439
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients will be included if they are having an in-patient spinal fusion procedure,are 18 years or older, post and post-operative pain control plan includes opioidmedications.
Exclusion
Exclusion Criteria:
- Pregnancy, age < 18, nursing, or documented allergy to naloxone
Study Design
Total Participants: 53
Treatment Group(s): 1
Primary Treatment: Naloxone
Phase: 4
Study Start date:
September 20, 2017
Estimated Completion Date:
February 20, 2020
Study Description
Connect with a study center
LUMC
Maywood, Illinois 60153
United StatesActive - Recruiting
Loyola University Medical Center
Maywood, Illinois 60153
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.